Viewing nowJayba Sujeong 5 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

MFDS item code 201707146 · Approved 2017.09.19
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medicine is used as an adjunct when dietary measures and exercise alone do not control primary hypercholesterolemia and mixed dyslipidemia. It also helps lower serum LDL cholesterol levels and delays the progression of atherosclerosis when used with dietary measures or other lipid-lowering therapies in patients with familial hypercholesterolemia. It is particularly effective in pediatric patients aged 10 to 17 who have persistent hypercholesterolemia. In adult patients at high risk for cardiovascular disease, it reduces the risks of stroke, myocardial infarction, and arterial revascularization procedures. Overall, this medication is used to reduce various types of dyslipidemia and the risk of cardiovascular disease.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer based on LDL cholesterol levels, treatment goals, and the patient's response, up to a maximum of 20 milligrams per day. 3. Elderly patients: No dose adjustment is needed. 4. Patients with renal impairment: No dose adjustment is needed in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Under 10 years of age: Safety and efficacy have not been established.
This medicine should not be used in certain patients. For instance, it should not be administered to individuals who are allergic to any of its ingredients, those with severely impaired liver function, muscle disorders, severe kidney impairment, pregnant or breastfeeding women, or fertile women who are not using appropriate contraception. Since this medication can affect liver health, caution is advised for patients with liver disease or those who consume alcohol excessively. It is important to have regular liver function tests before and during treatment. Muscle-related side effects such as myalgia or muscle weakness can occur, and rarely, rhabdomyolysis may present with severe muscle damage. If such symptoms occur, notify a doctor immediately, and discontinue medication if necessary. This medication may interact with other drugs, so caution is necessary when taken with specific antibiotics, antifungal medications, immunosuppressants, or fibrates. The risk of muscle-related side effects may increase with concomitant use. Women who are pregnant or planning to become pregnant should consult a doctor before taking this medication and utilize appropriate contraceptive methods. Breastfeeding women should also refrain from using this medication for safety. In cases of overdose, no specific antidote exists, and treatment should be symptomatic while monitoring liver function and muscle enzyme levels. When taking this medication, dizziness or headaches may occur, so caution is required when driving or operating machinery. Finally, this medicine contains lactose, so individuals with lactose intolerance or related genetic disorders should not take it.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, shortness of breath, diarrhea, oculobulbar weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, drug-induced erythroderma, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, appetite loss, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and light, and it is best kept at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's efficacy and ensure safe use.
Yellow round film-coated tablet
30 tablets/box [(10 tablets/Alu-Alu X 3)], 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.